Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celia Schiffer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|July 18, 2013
Interview with Celia SchifferCelia Schiffer
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2011
Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV bindingYufeng Cai, Celia Schiffer
Methods in Enzymology|December 31, 2003
Promise of advances in simulation methods for protein crystallography: implicit solvent models, time-averaging refinement, and quantum mechanical modelingCelia Schiffer, Jan Hermans
Handbook of Experimental Pharmacology|December 3, 2008
Viral protease inhibitorsJeffrey Anderson, Celia Schiffer, Sook-Kyung Lee, et al.
Proteins|May 3, 2007
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 proteaseSripriya Chellappan, Visvaldas Kairys, Miguel X Fernandes, et al.
Journal of Molecular Biology|February 20, 2002
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sitesCelia Schiffer, Mark Ultsch, Scott Walsh, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacityChris M Parry, Madhavi Kolli, Richard E Myers, et al.
Proteins|December 10, 2014
Modulation of HIV protease flexibility by the T80N mutationHao Zhou, Shangyang Li, John Badger, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2012
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistanceFarbod Babrzadeh, Vici Varghese, Mary Pacold, et al.
Human Vaccines & Immunotherapeutics|July 18, 2018
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and responseLeonard Moise, Bethany M Biron, Christine M Boyle, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|July 18, 2013
Interview with Celia SchifferCelia Schiffer
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2011
Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV bindingYufeng Cai, Celia Schiffer
Methods in Enzymology|December 31, 2003
Promise of advances in simulation methods for protein crystallography: implicit solvent models, time-averaging refinement, and quantum mechanical modelingCelia Schiffer, Jan Hermans
Handbook of Experimental Pharmacology|December 3, 2008
Viral protease inhibitorsJeffrey Anderson, Celia Schiffer, Sook-Kyung Lee, et al.
Proteins|May 3, 2007
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 proteaseSripriya Chellappan, Visvaldas Kairys, Miguel X Fernandes, et al.
Journal of Molecular Biology|February 20, 2002
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sitesCelia Schiffer, Mark Ultsch, Scott Walsh, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacityChris M Parry, Madhavi Kolli, Richard E Myers, et al.
Proteins|December 10, 2014
Modulation of HIV protease flexibility by the T80N mutationHao Zhou, Shangyang Li, John Badger, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2012
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistanceFarbod Babrzadeh, Vici Varghese, Mary Pacold, et al.
Human Vaccines & Immunotherapeutics|July 18, 2018
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and responseLeonard Moise, Bethany M Biron, Christine M Boyle, et al.
Pageof 1